SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
US Stock MarketDetailed Quotes
HOTH Hoth Therapeutics
- 0.7600
- -0.0270-3.43%
Close Dec 26 16:00 ET
- 0.7890
- +0.0290+3.82%
Post 19:59 ET
5.25MMarket Cap-0.60P/E (TTM)
0.8174High0.7011Low8.63MVolume0.8100Open0.7870Pre Close8.14MTurnover126.22%Turnover RatioLossP/E (Static)6.90MShares1.690052wk High0.70P/B5.20MFloat Cap0.580052wk Low--Dividend TTM6.84MShs Float347.0000Historical High--Div YieldTTM14.78%Amplitude0.5800Historical Low0.9430Avg Price1Lot Size
Hoth Therapeutics News
Hoth Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pavell Jeff
Hoth Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Sarnoff David
Hoth Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Knie Robb
Hoth Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Linsley Wayne
Hoth Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Knie Robb
Hoth Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)
Hoth Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Springer Graig
Hoth Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Sarnoff David
Hoth Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pavell Jeff
Hoth Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Linsley Wayne
Hoth Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Knie Robb
Hoth Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Sarnoff David
Hoth Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Springer Graig
Hoth Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Knie Robb
Hoth Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pavell Jeff
Hoth Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Linsley Wayne
Hoth Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Hoth Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(4.2%),Daniel B. Asher(4.2%), etc.
Hoth Therapeutics | D: Filing D
Hoth Therapeutics | 4: Statement of changes in beneficial ownership of securities